Harriet Mayanja-Kizza
#53,477
Most Influential Person Now
Ugandan academic
Harriet Mayanja-Kizza's AcademicInfluence.com Rankings
Harriet Mayanja-Kizzaphilosophy Degrees
Philosophy
#9260
World Rank
#12794
Historical Rank
Logic
#8318
World Rank
#10392
Historical Rank
Download Badge
Philosophy
Harriet Mayanja-Kizza's Degrees
- PhD Medical Microbiology Makerere University
- Masters Medical Microbiology Makerere University
- Bachelors Biology Makerere University
Similar Degrees You Can Earn
Why Is Harriet Mayanja-Kizza Influential?
(Suggest an Edit or Addition)According to Wikipedia, Harriet Mayanja-Kizza, MBChB, MMed, MSc, FACP, is a Ugandan physician, researcher, and academic administrator. She is the former Dean of Makerere University School of Medicine, the oldest medical school in East Africa, established in 1924.
Harriet Mayanja-Kizza's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A blood RNA signature for tuberculosis disease risk: a prospective cohort study (2016) (534)
- Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy. (2008) (282)
- Predictors of Long-Term Viral Failure Among Ugandan Children and Adults Treated With Antiretroviral Therapy (2007) (237)
- A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis (2004) (224)
- Impact of tuberculosis (TB) on HIV‐1 activity in dually infected patients (2001) (184)
- Four‐Gene Pan‐African Blood Signature Predicts Progression to Tuberculosis (2018) (180)
- Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities (2015) (169)
- Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection (2018) (165)
- Severe Sepsis in Two Ugandan Hospitals: a Prospective Observational Study of Management and Outcomes in a Predominantly HIV-1 Infected Population (2009) (153)
- IFN-γ-independent immune markers of Mycobacterium tuberculosis exposure (2019) (142)
- Metabolite changes in blood predict the onset of tuberculosis (2018) (139)
- Sero-prevalence and risk factors for hepatitis B virus infection among health care workers in a tertiary hospital in Uganda (2010) (133)
- Genome Scan of M. tuberculosis Infection and Disease in Ugandans (2008) (129)
- Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda. (2005) (127)
- Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS. (1998) (125)
- Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and symptoms suggestive of TB (2016) (124)
- The impact of early monitored management on survival in hospitalized adult Ugandan patients with severe sepsis: A prospective intervention study* (2012) (115)
- A prospective blood RNA signature for tuberculosis disease risk (2016) (106)
- Acceptance of Routine Testing for HIV among Adult Patients at the Medical Emergency Unit at a National Referral Hospital in Kampala, Uganda (2007) (104)
- Concise gene signature for point‐of‐care classification of tuberculosis (2015) (103)
- FCRL5 Delineates Functionally Impaired Memory B Cells Associated with Plasmodium falciparum Exposure (2015) (103)
- High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort (2011) (102)
- Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection (2009) (92)
- Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults (2012) (90)
- A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries. (2006) (79)
- Incidence and Predictors of Mortality and the Effect of Tuberculosis Immune Reconstitution Inflammatory Syndrome in a Cohort of TB/HIV Patients Commencing Antiretroviral Therapy (2011) (70)
- Linkage to HIV Care and Survival Following Inpatient HIV Counseling and Testing (2011) (68)
- An Autopsy Study Describing Causes of Death and Comparing Clinico-Pathological Findings among Hospitalized Patients in Kampala, Uganda (2012) (66)
- Missed Opportunities for HIV Testing and Late-Stage Diagnosis among HIV-Infected Patients in Uganda (2011) (65)
- Differential gene expression of activating Fcγ receptor classifies active tuberculosis regardless of human immunodeficiency virus status or ethnicity. (2014) (63)
- Resistance and Susceptibility to Mycobacterium tuberculosis Infection and Disease in Tuberculosis Households in Kampala, Uganda (2018) (62)
- Contact investigation for active tuberculosis among child contacts in Uganda. (2013) (62)
- Echocardiographic Diagnosis of Heart Disease in Uganda (1996) (61)
- RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response (2020) (61)
- Mycobacterium tuberculosis Bacteremia in a Cohort of HIV-Infected Patients Hospitalized with Severe Sepsis in Uganda–High Frequency, Low Clinical Sand Derivation of a Clinical Prediction Score (2013) (61)
- CD8+ T cells provide an immunologic signature of tuberculosis in young children. (2012) (61)
- HIV Counseling and Testing Practices at an Urban Hospital in Kampala, Uganda (2006) (56)
- Relapse more common than reinfection in recurrent tuberculosis 1-2 years post treatment in urban Uganda. (2013) (56)
- Mind the gaps: a qualitative study of perceptions of healthcare professionals on challenges and proposed remedies for cervical cancer help-seeking in post conflict northern Uganda (2013) (55)
- Bacteriuria among adult non-pregnant women attending Mulago hospital assessment centre in Uganda. (2011) (55)
- Analysis of Host Responses to Mycobacterium tuberculosis Antigens in a Multi-Site Study of Subjects with Different TB and HIV Infection States in Sub-Saharan Africa (2013) (54)
- Multi-center evaluation of a user-friendly lateral flow assay to determine IP-10 and CCL4 levels in blood of TB and non-TB cases in Africa. (2016) (54)
- Transcriptional networks are associated with resistance to Mycobacterium tuberculosis infection (2017) (53)
- Point-of-care lactate testing predicts mortality of severe sepsis in a predominantly HIV type 1-infected patient population in Uganda. (2008) (52)
- Polymorphisms in TICAM2 and IL1B are associated with TB (2014) (51)
- Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study (2008) (50)
- Clinical and epidemiological characteristics of individuals resistant to M. tuberculosis infection in a longitudinal TB household contact study in Kampala, Uganda (2014) (48)
- Lopinavir/ritonavir significantly influences pharmacokinetic exposure of artemether/lumefantrine in HIV-infected Ugandan adults (2012) (47)
- Atorvastatin reduces T-cell activation and exhaustion among HIV-infected cART-treated suboptimal immune responders in Uganda: a randomised crossover placebo-controlled trial (2015) (46)
- Mentorship needs at academic institutions in resource-limited settings: a survey at makerere university college of health sciences (2011) (46)
- Greater Diversity of HIV‐1 Quasispecies in HIV‐Infected Individuals With Active Tuberculosis (2000) (45)
- Determinants of hypertension in a young adult Ugandan population in epidemiological transition—the MEPI-CVD survey (2015) (45)
- Whole Blood Interferon-Gamma Responses to Mycobacterium tuberculosis Antigens in Young Household Contacts of Persons with Tuberculosis in Uganda (2008) (44)
- Cellular Immune Activation in Cerebrospinal Fluid From Ugandans With Cryptococcal Meningitis and Immune Reconstitution Inflammatory Syndrome (2014) (44)
- LPS-Binding Protein and IL-6 Mark Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome in HIV Patients (2013) (43)
- Mycobacterium tuberculosis Specific CD8+ T Cells Rapidly Decline with Antituberculosis Treatment (2013) (43)
- Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda (2015) (40)
- Total lymphocyte count of 1200 is not a sensitive predictor of CD4 lymphocyte count among patients with HIV disease in Kampala, Uganda. (2004) (39)
- Africa-wide evaluation of host biomarkers in QuantiFERON supernatants for the diagnosis of pulmonary tuberculosis (2018) (38)
- Clinical Spectrum, Risk Factors and Outcome of Immune Reconstitution Inflammatory Syndrome in Patients with Tuberculosis–HIV Coinfection (2012) (37)
- Urinary Lipoarabinomannan as Predictor for the Tuberculosis Immune Reconstitution Inflammatory Syndrome (2011) (37)
- Abbreviated HIV counselling and testing and enhanced referral to care in Uganda: a factorial randomised controlled trial (2013) (36)
- Endomyocardial fibrosis syndrome in Uganda (2000) (36)
- Modulation of the complement system in monocytes contributes to tuberculosis-associated immune reconstitution inflammatory syndrome (2013) (36)
- Mechanisms of Apoptosis of T-Cells in Human Tuberculosis (2005) (36)
- Autopsy acceptance rate and reasons for decline in Mulago Hospital, Kampala, Uganda (2011) (35)
- Potential for false positive HIV test results with the serial rapid HIV testing algorithm (2012) (35)
- Antiretroviral Treatment-Associated Tuberculosis in a Prospective Cohort of HIV-Infected Patients Starting ART (2010) (35)
- Eligibility for HIV/AIDS treatment among adults in a medical emergency setting at an urban hospital in Uganda. (2007) (34)
- A Serum Circulating miRNA Signature for Short-Term Risk of Progression to Active Tuberculosis Among Household Contacts (2018) (34)
- Activation of beta-chemokines and CCR5 in persons infected with human immunodeficiency virus type 1 and tuberculosis. (2001) (34)
- Evaluation of Cepheid's Xpert MTB/RIF Test on Pleural Fluid in the Diagnosis of Pleural Tuberculosis in a High Prevalence HIV/TB Setting (2014) (33)
- Worsening and unmasking of tuberculosis in HIV-1 infected patients after initiating highly active anti-retroviral therapy in Uganda. (2008) (33)
- Hypoglycemia at admission is associated with inhospital mortality in Ugandan patients with severe sepsis* (2011) (33)
- Long-term stability of resistance to latent M. tuberculosis infection in highly exposed TB household contacts in Kampala, Uganda. (2018) (33)
- Endomyocardial fibrosis: why is there striking ascites with little or no peripheral oedema? (1996) (32)
- Comprehensive definition of human immunodominant CD8 antigens in tuberculosis (2017) (32)
- The Effect of a Bidirectional Exchange on Faculty and Institutional Development in a Global Health Collaboration (2015) (31)
- Predictors of treatment failure among pulmonary tuberculosis patients in Mulago hospital, Uganda. (2011) (30)
- Evaluation of Dynabeads and Cytospheres Compared With Flow Cytometry to Enumerate CD4+ T Cells in HIV-Infected Ugandans on Antiretroviral Therapy (2008) (30)
- Prevalence and risk factors of latent Tuberculosis among adolescents in rural Eastern Uganda. (2015) (30)
- Interaction between host genes and Mycobacterium tuberculosis lineage can affect tuberculosis severity: Evidence for coevolution? (2020) (30)
- Digital clubbing in tuberculosis – relationship to HIV infection, extent of disease and hypoalbuminemia (2006) (29)
- Polyfunctional Mycobacterium tuberculosis-specific effector memory CD4+ T cells at sites of pleural TB. (2011) (29)
- Opportunities and barriers for implementation of integrated TB and HIV care in lower level health units: experiences from a rural western Ugandan district. (2010) (29)
- Challenges in diagnosis and management of Cryptococcal immune reconstitution inflammatory syndrome (IRIS) in resource limited settings. (2012) (29)
- Diagnostic Accuracy of the Cepheid 3-gene Host Response Fingerstick Blood Test in a Prospective, Multi-site Study: Interim Results (2021) (29)
- Diagnostic Accuracy of the Cepheid 3-gene Host Response Fingerstick Blood Test in a Prospective, Multi-site Study: Interim Results (2021) (29)
- B cell sub-types following acute malaria and associations with clinical immunity (2016) (29)
- Prevalence of HIV-Associated Metabolic Abnormalities among Patients Taking First-Line Antiretroviral Therapy in Uganda (2012) (29)
- An Early Morning Sputum Sample Is Necessary for the Diagnosis of Pulmonary Tuberculosis, Even with More Sensitive Techniques: A Prospective Cohort Study among Adolescent TB-Suspects in Uganda (2012) (29)
- Vitamin D deficiency among adult patients with tuberculosis: a cross sectional study from a national referral hospital in Uganda (2013) (29)
- Strengthening evidence-based healthcare in Africa (2013) (29)
- Doctoral training in Uganda: evaluation of mentoring best practices at Makerere university college of health sciences (2014) (27)
- Distinct cytokine and regulatory T cell profile at pleural sites of dual HIV/tuberculosis infection compared to that in the systemic circulation (2011) (27)
- Functional adrenal insufficiency among critically ill patients with human immunodeficiency virus in a resource-limited setting. (2007) (27)
- A side-by-side comparison of T cell reactivity to fifty-nine Mycobacterium tuberculosis antigens in diverse populations from five continents. (2015) (27)
- Distinct T-cell responses when BCG vaccination is delayed from birth to 6 weeks of age in Ugandan infants. (2014) (27)
- Mortality and Immunological Recovery Among Older Adults on Antiretroviral Therapy at a Large Urban HIV Clinic in Kampala, Uganda (2014) (26)
- The medical management of central nervous system infections in Uganda and the potential impact of an algorithm-based approach to improve outcomes. (2007) (26)
- Pharmacokinetics and pharmacodynamics of intravenous artesunate during severe malaria treatment in Ugandan adults (2012) (25)
- Update on the efficacy, effectiveness and safety of artemether–lumefantrine combination therapy for treatment of uncomplicated malaria (2009) (25)
- A chromosome 5q31.1 locus associates with tuberculin skin test reactivity in HIV-positive individuals from tuberculosis hyper-endemic regions in east Africa (2017) (25)
- Macrophage-activating cytokines in human immununodeficiency virus type 1-infected and -uninfected patients with pulmonary tuberculosis. (2001) (25)
- Evaluation of cytokine responses against novel Mtb antigens as diagnostic markers for TB disease. (2016) (25)
- Low prevalence of vitamin D deficiency in Ugandan HIV-infected patients with and without tuberculosis. (2012) (24)
- Correction: Mycobacterium tuberculosis Bacteremia in a Cohort of HIV-Infected Patients Hospitalized with Severe Sepsis in Uganda–High Frequency, Low Clinical Suspicion and Derivation of a Clinical Prediction Score (2013) (24)
- Early virological response of zidovudine/lamivudine/abacavir for patients co-infected with HIV and tuberculosis in Uganda (2007) (24)
- Neutrophil Activation and Enhanced Release of Granule Products in HIV-TB Immune Reconstitution Inflammatory Syndrome (2017) (24)
- Prevalence of hepatitis B and C and relationship to liver damage in HIV infected patients attending Joint Clinical Research Centre Clinic (JCRC), Kampala, Uganda. (2015) (23)
- Resurrecting the triple threat: academic social responsibility in the context of global health research. (2009) (23)
- Artemether-Lumefantrine Combination Therapy for Treatment of Uncomplicated Malaria: The Potential for Complex Interactions with Antiretroviral Drugs in HIV-Infected Individuals (2011) (23)
- Towards reframing health service delivery in Uganda: the Uganda Initiative for Integrated Management of Non-Communicable Diseases (2015) (23)
- Reframing undergraduate medical education in global health: Rationale and key principles from the Bellagio Global Health Education Initiative (2017) (23)
- Global Health Education in the Time of COVID-19: An Opportunity to Restructure Relationships and Address Supremacy (2020) (23)
- Suitability of saliva for Tuberculosis diagnosis: comparing with serum (2017) (22)
- Tuberculosis Treatment in HIV Infected Ugandans with CD4 Counts >350 Cells/mm3 Reduces Immune Activation with No Effect on HIV Load or CD4 Count (2010) (22)
- Trends of admissions and case fatality rates among medical in-patients at a tertiary hospital in Uganda; A four-year retrospective study (2019) (22)
- Burden of tuberculosis disease among adolescents in a rural cohort in Eastern Uganda (2013) (22)
- Key bottlenecks to the provision of safe obstetric anaesthesia in low- income countries; a cross-sectional survey of 64 hospitals in Uganda (2017) (22)
- Association of genetic variation with blood pressure traits among East Africans (2017) (21)
- Systemic immune activation and microbial translocation in dual HIV/tuberculosis-infected subjects. (2013) (20)
- Impaired T-cell proliferation among HAART-treated adults with suboptimal CD4 recovery in an African cohort (2013) (20)
- Effect of Tuberculosis Preventive Therapy on HIV Disease Progression and Survival in HIV-Infected Adults (2006) (20)
- A randomized trial of punctuated antiretroviral therapy in Ugandan HIV-seropositive adults with pulmonary tuberculosis and CD4⁺ T-cell counts of ≥ 350 cells/μL. (2011) (20)
- Genetic susceptibility to tuberculosis associated with cathepsin Z haplotype in a Ugandan household contact study. (2011) (20)
- Effects of antiretroviral therapy on immune function of HIV-infected adults with pulmonary tuberculosis and CD4+ >350 cells/mm3. (2011) (20)
- Genetic and shared environmental influences on interferon-γ production in response to Mycobacterium tuberculosis antigens in a Ugandan population. (2013) (19)
- Protective Responses in Tuberculosis: Induction of Genes for Interferon‐γ and Cytotoxicity by Mycobacterium tuberculosis and During Human Tuberculosis (2004) (19)
- Dynamic variation in the cellular origin of HIV type 1 during treatment of tuberculosis in dually infected subjects. (2007) (19)
- High CD56++CD16- natural killer (NK) cells among suboptimal immune responders after four years of suppressive antiretroviral therapy in an African adult HIV treatment cohort (2014) (19)
- Avidity of anti-malarial antibodies inversely related to transmission intensity at three sites in Uganda (2017) (18)
- Inhibition of human immunodeficiency virus‐1 (HIV‐1) by β‐chemokine analogues in mononuclear cells from HIV‐1‐infected patients with active tuberculosis (2005) (18)
- Tuberculosis and human immunodeficiency virus co-infections and their predictors at a hospital-based HIV/AIDS clinic in Uganda. (2010) (18)
- What is the most reliable solid culture medium for tuberculosis treatment trials? (2014) (18)
- Lower Pre-Treatment T Cell Activation in Early- and Late-Onset Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome (2015) (18)
- Validation and Optimization of Host Immunological Bio-Signatures for a Point-of-Care Test for TB Disease (2021) (17)
- Diagnostic accuracy of fine needle aspiration cytology in providing a diagnosis of cervical lymphadenopathy among HIV-infected patients. (2015) (17)
- The Interaction of Monocyte Chemoattractant Protein‐1 and Tumour Necrosis Factor‐α in Mycobacterium tuberculosis‐induced HIV‐1 Replication at Sites of Active Tuberculosis (2009) (16)
- A need to accelerate health research productivity in an African University: the case of Makerere University College of Health Sciences (2017) (16)
- Monocyte Phenotype and IFN-γ-Inducible Cytokine Responses Are Associated with Cryptococcal Immune Reconstitution Inflammatory Syndrome (2017) (16)
- Activation of P-TEFb at sites of dual HIV/TB infection, and inhibition of MTB-induced HIV transcriptional activation by the inhibitor of CDK9, Indirubin-3'-monoxime. (2012) (16)
- Immune Activation at Sites of HIV/TB Co-Infection Contributes to the Pathogenesis of HIV-1 Disease (2016) (16)
- Cardiac Conduction Safety during Coadministration of Artemether-Lumefantrine and Lopinavir/Ritonavir in HIV-Infected Ugandan Adults (2011) (14)
- Antigen-Specific Interferon-Gamma Responses and Innate Cytokine Balance in TB-IRIS (2014) (13)
- Two year mortality and associated factors in a cohort of children from rural Uganda (2014) (13)
- Impact of mouth rinsing before sputum collection on culture contamination. (2009) (13)
- Delayed-type hypersensitivity skin test reactivity and survival in HIV-infected patients in Uganda: should anergy be a criterion to start antiretroviral therapy in low-income countries? (2006) (13)
- Tuberculin Skin Test Reversion following Isoniazid Preventive Therapy Reflects Diversity of Immune Response to Primary Mycobacterium tuberculosis Infection (2014) (13)
- Tuberculin skin test conversion among HIV patients on antiretroviral therapy in Uganda. (2013) (13)
- Induction of HIV type 1 expression correlates with T cell responsiveness to mycobacteria in patients coinfected with HIV type 1 and Mycobacterium tuberculosis. (2009) (13)
- Treatment of severe sepsis with artemether-lumefantrine is associated with decreased mortality in Ugandan patients without malaria. (2009) (13)
- Steady-state pharmacokinetic comparison of generic and branded formulations of stavudine, lamivudine and nevirapine in HIV-infected Ugandan adults. (2008) (13)
- Predictors for MTB Culture-Positivity among HIV-Infected Smear-Negative Presumptive Tuberculosis Patients in Uganda: Application of New Tuberculosis Diagnostic Technology (2015) (13)
- Medical Education Capacity-Building Partnerships for Health Care Systems Development. (2016) (12)
- Tropical endomyocardial fibrosis in Uganda: the tribal and geographic distribution, and the association with eosinophilia. (2000) (12)
- Inhibition of human immunodeficiency virus-1 (HIV-1) by beta-chemokine analogues in mononuclear cells from HIV-1-infected patients with active tuberculosis. (2005) (12)
- Global medical education partnerships to expand specialty expertise: a case report on building neurology clinical and research capacity (2014) (12)
- Feasibility of establishing a biosafety level 3 tuberculosis culture laboratory of acceptable quality standards in a resource-limited setting: an experience from Uganda (2015) (12)
- Prevalence and factors associated with dental caries in patients attending an HIV care clinic in Uganda: a cross sectional study (2019) (11)
- OUTCOMES OF CRYPTOCOCCAL MENINGITIS IN UGANDA BEFORE AND AFTER THE AVAILABILITY OF HAART (2008) (11)
- Effect of anti-retroviral therapy on oxidative stress in hospitalized HIV-infected adults with and without TB (2018) (11)
- Evaluation of in-house PCR for diagnosis of smear-negative pulmonary tuberculosis in Kampala, Uganda (2012) (10)
- Bridging research integrity and global health epidemiology (BRIDGE) statement: guidelines for good epidemiological practice (2020) (10)
- Therapeutic Evaluation of Polyamine Analogue Drug Candidates against Enterocytozoon bieneusi in a SCID Mouse Model (2009) (10)
- Towards reframing health service delivery in Uganda: the Uganda Initiative for Integrated Management of Non-Communicable Diseases. (2015) (10)
- Postnatal Expansion, Maturation, and Functionality of MR1T Cells in Humans (2019) (10)
- Prevention of Early Mortality by Presumptive Tuberculosis Therapy Study: An Open Label, Randomized Controlled Trial. (2016) (10)
- Low antigen-specific CD4 T-cell immune responses despite normal absolute CD4 counts after long-term antiretroviral therapy an African cohort. (2014) (9)
- Intravenous artesunate plus Artemisnin based Combination Therapy (ACT) or intravenous quinine plus ACT for treatment of severe malaria in Ugandan children: a randomized controlled clinical trial (2017) (9)
- Clinical Differences between Younger and Older Adults with HIV/AIDS Starting Antiretroviral Therapy in Uganda and Zimbabwe: A Secondary Analysis of the DART Trial (2013) (9)
- Diagnostic accuracy of ultrasensitive heat-denatured HIV-1 p24 antigen in non-B subtypes in Kampala, Uganda (2011) (8)
- Genetic Variation in TLR Genes in Ugandan and South African Populations and Comparison with HapMap Data (2012) (8)
- Reasons for non-participation in an international multicenter trial of a new drug for tuberculosis treatment. (2012) (8)
- CD4+ T cell polyfunctional profile in HIV-TB coinfection are similar between individuals with latent and active TB infection. (2015) (8)
- Genetic variability and consequence of Mycobacterium tuberculosis lineage 3 in Kampala-Uganda (2019) (8)
- CD4 T-cell activation and reduced regulatory T-cell populations are associated with early development of cataracts among HIV-infected adults in Uganda. (2014) (7)
- How we determined the most reliable solid medium for studying treatment of tuberculosis. (2014) (7)
- Impact of a Rapid Decline in Malaria Transmission on Antimalarial IgG Subclasses and Avidity (2020) (7)
- Extensive dental caries in a HIV positive adult patient on ART; case report and literature review (2018) (7)
- Unexpected low-level viremia among HIV-infected Ugandan adults with untreated active tuberculosis. (2008) (7)
- Increased KLRG1 and PD-1 expression on CD8 T lymphocytes in TB-IRIS (2019) (6)
- MyD88‐dependent pathway is essential for the innate immunity to Enterocytozoon bieneusi (2011) (5)
- Opportunistic diseases diminish the clinical benefit of immediate antiretroviral therapy in HIV–tuberculosis co-infected adults with low CD4+ cell counts (2018) (5)
- Monocyte metabolic transcriptional programs associate with resistance to tuberculin skin test/interferon-γ release assay conversion. (2021) (5)
- Past and Present Approaches to Diagnosis of Active Pulmonary Tuberculosis (2021) (4)
- Monocyte Transcriptional Responses to Mycobacterium tuberculosis Associate with Resistance to Tuberculin Skin Test and Interferon Gamma Release Assay Conversion (2022) (4)
- T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection (2023) (4)
- Socially Accountable Global Health Education Amidst Political Uncertainty and Reactionary Nationalism: A Value Proposition and Recommendations for Action (2019) (4)
- Dental Caries Pattern and Treatment Needs among Ugandan Adolescent Students: A Cross-Sectional Study (2020) (4)
- Chest X-ray interpretation does not complement Xpert MTB/RIF in diagnosis of smear-negative pulmonary tuberculosis among TB-HIV co-infected adults in a resource-limited setting (2020) (4)
- Recognition of CD8+ T-cell epitopes to identify adults with pulmonary tuberculosis (2019) (4)
- Why Evidence Based Approaches are urgently needed in Africa. (2014) (4)
- Importance of study design and phenotype definition in ongoing studies of resistance to latent M. tuberculosis infection. (2020) (4)
- Immune cells in bronchoalveolar lavage fluid of Ugandan adults who resist versus those who develop latent Mycobacterium tuberculosis infection (2021) (3)
- A 10-year retrospective study of lung cancer in Uganda (2021) (3)
- Novel HLA associations with outcomes of Mycobacterium tuberculosis exposure and sarcoidosis in individuals of African ancestry using nearest‐neighbor feature selection (2022) (3)
- Interaction between host genes and M. tuberculosis lineage can affect tuberculosis severity: evidence for coevolution (2019) (3)
- Concurrent evaluation of cytokines improves the accuracy of antibodies against Mycobacterium tuberculosis antigens in the diagnosis of active tuberculosis. (2022) (3)
- Resistance to TST/IGRA conversion in Uganda: Heritability and Genome-Wide Association Study (2021) (3)
- Interaction between M. tuberculosis Lineage and Human Genetic Variants Reveals Novel Pathway Associations with Severity of TB (2021) (3)
- Enrichment of HIV-1 Subtype AD Recombinants in a Ugandan Cohort of Severely Septic Patients (2012) (3)
- HDAC3 inhibitor RGFP966 controls bacterial growth and modulates macrophage signaling during Mycobacterium tuberculosis infection. (2021) (3)
- Expansion and productive HIV-1 infection of Foxp3 positive CD4 T cells at pleural sites of HIV/TB co-infection. (2016) (3)
- Hyperlactatemia and concurrent use of antiretroviral therapy among HIV infected patients in Uganda. (2013) (3)
- Erratum to: B cell sub-types following acute malaria and associations with clinical immunity (2016) (3)
- Immune response to the hepatitis B vaccine among HIV-infected adults in Uganda. (2021) (3)
- One dollar incentive improves tuberculosis treatment outcomes in programmatic settings in rural Uganda (2021) (2)
- Productive HIV-1 infection is enriched in CD4-CD8- double negative (DN) T cells at pleural sites of dual infection with HIV and Mycobacterium tuberculosis (2015) (2)
- Tracing Makerere University's 100 years' contribution to lung science/medicine (2022) (2)
- Research priorities for HIV/M. tuberculosis co-infection (2011) (2)
- Short Communication: Expression of APOBEC3G and Interferon Gamma in Pleural Fluid Mononuclear Cells from HIV/TB Dual Infected Subjects. (2015) (2)
- Publisher Correction: IFN-γ-independent immune markers of Mycobacterium tuberculosis exposure (2019) (2)
- A Side-by-side Comparison of T cell Reactivity to Fifty-nine M . tuberculosis Antigens in Diverse Populations from five Continents (2)
- OC 8435 MULTI-BIOMARKER TEST STRIP FOR POINT-OF-CARE SCREENING FOR ACTIVE TUBERCULOSIS: A FIVE-COUNTRY MULTI-CENTRE TEST EVALUATION (2019) (2)
- Infectious Diseases Institute at Makerere University College of Health Sciences: a case study of a sustainable capacity building model for health care, research and training (2022) (2)
- Towards a Universal Medical Education Global Health Curriculum: Update on the Bellagio Global Health Education Initiative (2017) (2)
- Short communication: circulating plasma HIV-1 viral protein R in dual HIV-1/tuberculosis infection. (2014) (2)
- Progression to active Tuberculosis among household contacts (2018) (2)
- TRANSLATION AND DETERMINATION OF THE COMPREHENSIBILITY OF A LUGANDA VERSION OF ORAL MUCOSITIS DAILY QUESTIONNAIRE. (2021) (2)
- Avidity of anti-malarial antibodies inversely related to transmission intensity at three sites in Uganda (2017) (1)
- Endomyocardial fibrosis: is it a systemic disease? (2016) (1)
- Mtb-Specific CD8+ T Cell Responses Decline With Antituberculous Therapy In Smear-Positive Pulmonary TB Cases In Kampala, Uganda (2011) (1)
- The effect of interrupted anti-retroviral treatment on the reconstitution of memory and naive T cells during tuberculosis treatment in HIV patients with active pulmonary tuberculosis (2017) (1)
- Impaired T-cell proliferation among HAART-treated adults with suboptimal CD4 recovery in an African cohort (2013) (1)
- Tuberculosis severity associates with variants and eQTLs related to vascular biology and infection-induced inflammation (2022) (1)
- Selective HDAC3 Inhibitor Restricts Mycobacterial Growth and Modulates Macrophage Immune Responses (2019) (1)
- CD4 T-cell cytokine correlates of diagnostic tests for latent tuberculous infection in HIV-1-infected subjects. (2015) (1)
- Equitable Access to Health Professional Training in Uganda: A Cross Sectional Study (2018) (1)
- Improved Diagnostic Accuracy for Active Tuberculosis in Ugandan Children Using a CD8 ELISPOT Assay. (2009) (1)
- Determinants of Clinician Knowledge on Aging and HIV/AIDS: A Survey of Practitioners and Policy Makers in Kampala District, Uganda (2013) (1)
- Interferon-γ release assays or tuberculin skin test for latent tuberculosis infection? (2020) (1)
- Doctoral training in Uganda: evaluation of mentoring best practices at Makerere university college of health sciences (2014) (1)
- Potential for false positive HIV test results with the serial rapid HIV testing algorithm (2012) (1)
- Experiences of patients who developed oral mucositis during solid neoplasms treatment: a Ugandan qualitative study (2021) (1)
- ' s response to reviews Title : Response to M . tuberculosis selected RD 1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis : a pilot study (2007) (1)
- B cell sub-types following acute malaria and associations with clinical immunity (2016) (1)
- Polyfunctional M. tuberculosis-specific effector memory CD4+ T cells at sites of pleural TB (2012) (1)
- Resistance patterns of Plasmodium falciparum malaria to chloroquine in Kampala, Uganda. (2002) (1)
- The role of histone deacetylases in the innate immune response to Mycobacterium tuberculosis infection (2016) (1)
- Evaluation of in-house PCR for diagnosis of smear-negative pulmonary tuberculosis in Kampala, Uganda (2012) (1)
- Methylome-wide analysis reveals epigenetic marks associated with resistance to tuberculosis in HIV-infected individuals from East Africa. (2021) (0)
- Airway microbiome-immune crosstalk in chronic obstructive pulmonary disease (2023) (0)
- 336. Developing a Protein Signature of Early Latent Tuberculosis Infection. (2022) (0)
- Association between IFN- γ levels and rs3212227 genotype using available data combined cohorts. (2020) (0)
- HIV, tuberculosis, diabetes mellitus and hypertension admissions and premature mortality among adults in Uganda from 2011 to 2019: is the tide turning? (2022) (0)
- Diagnostic Performance of a Seven-marker Serum Protein Biosignature for the Diagnosis 17 of Active TB Disease in African Primary Health Care Clinic Attendees with Signs and 18 Symptoms Suggestive of TB 19 20 (2020) (0)
- Prevention of tuberculosis in HIV infection with novel drugs. (2020) (0)
- Description of supplemental methods and supplemental citations. (2020) (0)
- Mentoring for sustainable in-country academic leadership in resource-limited settings (2015) (0)
- Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection (2018) (0)
- T-reg are the Predominant CD4 + T-Cell Subset Productively Infected with HIV-1 at Sites of Dual HIV/TB Infection (2015) (0)
- Methylome-wide analysis reveals epigenetic marks associated with resistance to tuberculosis in HIV-infected individuals from East Africa (2020) (0)
- THU-232-Hepatitis B vaccination is effective among HIV-infected adults in Uganda (2019) (0)
- Vitamin D deficiency among adult patients with tuberculosis: a cross sectional study from a national referral hospital in Uganda (2013) (0)
- Mortality and its associated factors in transfused patients at a tertiary hospital in Uganda (2022) (0)
- Extensive dental caries in a HIV positive adult patient on ART; case report and literature review (2018) (0)
- The Clinical Presentation and Factors Associated with Disease Severity of Rheumatoid Arthritis in Uganda: A Cross-Sectional Study (2022) (0)
- Comprehensive definition of human immunodominant CD8 antigens in tuberculosis (2017) (0)
- Distribution of MTB lineages in cohort 1, cohort 2, and combined cohorts. (2020) (0)
- The Diagnostic Potential of the CD8+T Cell Response: Identification of Immunodominant CD8+T Cell Antigens and the Potential To Differentiate Latent from Active Tuberculosis. (2009) (0)
- Optimal therapy for multidrug-resistant tuberculosis and HIV (2020) (0)
- Productive HIV-1 infection is enriched in CD4-CD8- double negative (DN) T cells at pleural sites of dual infection with HIV and Mycobacterium tuberculosis (2015) (0)
- Microbial characteristics of dental caries in HIV positive individuals (2022) (0)
- Structured career development for global health research in resource-limited settings: A pilot of career development series for faculty at Makerere university college of health sciences (2015) (0)
- IFN-γ-independent immune markers of Mycobacterium tuberculosis exposure (2019) (0)
- Editorial: Immuno-diagnosis of active tuberculosis; are we making progress? (2023) (0)
- Lack of elevated pre-ART elastase-ANCA levels in patients developing TB-IRIS (2020) (0)
- MR1-restricted T cell clonotypes are associated with ‘resistance’ to M.tuberculosis infection (2022) (0)
- kimma: flexible linear mixed effects modeling with kinship covariance for RNA-seq data (2022) (0)
- Studies examining the relative role of FAI in HIV / AIDS patients with sepsis and other severe illnesses (2007) (0)
- Publisher Correction: IFN-γ-independent immune markers of Mycobacterium tuberculosis exposure (2019) (0)
- Mycobacterium tuberculosis and human immunodeficiency virus type 1 interaction: Pathogenesis and disease modulation in dual infection (2014) (0)
- Prevalence and factors associated with dental caries in patients attending an HIV care clinic in Uganda: a cross sectional study (2019) (0)
- Differentially expressed transcript isoforms associate with resistance to tuberculin skin test and interferon gamma release assay conversion (2023) (0)
- Metabolite changes in blood predict the onset of tuberculosis (2018) (0)
- RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response (2020) (0)
- Erratum to: B cell sub-types following acute malaria and associations with clinical immunity (2016) (0)
- PREventing Maternal And Neonatal Deaths in Rural Northern Ghana (PREMAND): Access to Basic and Comprehensive Obstetric Care (2017) (0)
- Pharmacokinetics and pharmacodynamics of intravenous artesunate during severe malaria treatment in Ugandan adults (2012) (0)
- High CD56++CD16- natural killer (NK) cells among suboptimal immune responders after four years of suppressive antiretroviral therapy in an African adult HIV treatment cohort (2014) (0)
- A Standardized Approach for Collection of Objective Data to Support Outcome Determination for Late-Phase TB Trials. (2023) (0)
- Regression results for association between rs17235409 and TBscore, adjusted for HIV status and lineage. (2020) (0)
- Africa-wide evaluation of host biomarkers in QuantiFERON supernatants for the diagnosis of pulmonary tuberculosis (2018) (0)
- The value of aspiration biopsy cytology in lymphomas: its accuracy and application. (1985) (0)
- Differential expression of host protein biomarkers among symptomatic clinic attendees finally diagnosed with tuberculosis and other respiratory diseases with or without latent Mycobacterium tuberculosis infection. (2022) (0)
- Accuracy of an ‘in-house’ sputum polymerase chain reaction assay for rapid diagnosis of sputum smear negative pulmonary tuberculosis at Mulago hospital, Uganda (2010) (0)
- OC 8405 IDENTIFICATION OF AN MTB-SPECIFIC SOLUBLE HOST SIGNATURE FOR RISK OF DEVELOPMENT OF ACTIVE TB IN HIV-POSITIVE MTB-EXPOSED CONTACTS (2019) (0)
- A 10-year retrospective study of lung cancer in Uganda (2022) (0)
- sepsis study poster (2013) (0)
This paper list is powered by the following services:
Other Resources About Harriet Mayanja-Kizza
What Schools Are Affiliated With Harriet Mayanja-Kizza?
Harriet Mayanja-Kizza is affiliated with the following schools:
